Caltagirone SpA (CALT)

CALT Revenue

Calliditas Therapeutics AB had revenue of 1.09B EUR in the half year ending June 30, 2025, with 14.51% growth. This brings the company's revenue in the last twelve months to 2.22B, up 12.16% year-over-year. In the year 2024, Calliditas Therapeutics AB had annual revenue of 2.11B with 8.54% growth.

• Revenue (ttm): 2.22B EUR
• Revenue Growth: +12.16%
• P/S Ratio: 0.48
• Revenue / Employee: 564,684 EUR
• Employees: 3,925
• Market Cap: 1.26B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.11B	165.97M	8.54%
Dec 31, 2023	1.94B	3.73M	0.19%
Dec 31, 2022	1.94B	364.11M	23.10%
Dec 31, 2021	1.58B	141.77M	9.88%
Dec 31, 2020	1.43B	-22.01M	-1.51%